Maternus-Kliniken AG

Total Valuation

Maternus-Kliniken AG carries a market capitalization of 20.76M, placing it among publicly traded companies globally. Its enterprise value stands at 112.22M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Maternus-Kliniken AG currently has 20.97M shares outstanding.

Valuation Ratios

Maternus-Kliniken AG trades at a trailing price-to-earnings ratio of 12.63. The price-to-sales ratio is 0.24, and the price-to-book ratio stands at -2.36.

Enterprise Valuation

On an enterprise value basis, Maternus-Kliniken AG trades at an EV/EBITDA multiple of 13.88 and an EV/FCF ratio of 30.88. The EV/Sales ratio of 0.91 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 13.88 provides insight into valuation relative to core operating earnings.

Financial Position

Maternus-Kliniken AG maintains a current ratio of 0.49, meaning it holds 0.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -2,591.14, indicating conservative leverage, while an interest coverage ratio of 1.56 demonstrates limited ability to service its debt obligations.

Financial Efficiency

Taxes

Over the trailing twelve months, Maternus-Kliniken AG has paid 511,000.00 in income taxes, reflecting an effective tax rate of 17.80.

Stock Price Statistics

Maternus-Kliniken AG's stock has declined approximately -28.77698% over the past 52 weeks. The 50-day moving average sits at 0.97, while the 200-day moving average is 1.04.

Income Statement

Over the trailing twelve months, Maternus-Kliniken AG generated 123.27M in revenue and converted that into 2.36M in net income, yielding earnings per share of 0.10. EBITDA reached 8.09M, while operating income came in at 8.09M.

Balance Sheet

Maternus-Kliniken AG holds 5.87M in cash and equivalents against 88.31M in total debt, resulting in a net debt position of 75.91M. Total book value stands at -12.64M, with working capital of -15.24M providing operational flexibility.

Cash Flow

Maternus-Kliniken AG produced -2.91M in operating cash flow over the past twelve months. After subtracting -2.28M in capital expenditures, free cash flow totaled -5.18M - equivalent to -0.23 per share.

Margins

Maternus-Kliniken AG operates with a gross margin of 83.16, reflecting its pricing power and cost economics. The operating margin of 6.56 and net profit margin of 1.91 provide insight into operational efficiency.

Dividends & Yields

Scores

Maternus-Kliniken AG posts an Altman Z-Score of 0.57, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.